Copyright
©The Author(s) 2023.
World J Cardiol. May 26, 2023; 15(5): 253-261
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.253
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.253
Table 1 Characteristics of aortic stenosis patients with different grades of mitral regurgitation
| 0 or 1+ MR | 2+ MR | 3 or 4+ MR | P value | |
| Age (yr) | 70 ± 12 | 74 ± 9 | 72 ± 13 | < 0.05 |
| Women (%) | 44 | 48 | 51 | 0.4 |
| Syncope (%) | 3 | 4 | 4 | 0.85 |
| Angina (%) | 38 | 49 | 47 | 0.12 |
| Dyspnea (%) | 39 | 38 | 62 | 0.002 |
| Atrial fibrillation (%) | 24 | 32 | 33 | 0.18 |
| Hypertension (%) | 58 | 57 | 44 | 0.06 |
| Diabetes mellitus (%) | 24 | 22 | 18 | 0.4 |
| Coronary artery disease (%) | 53 | 60 | 58 | 0.3 |
| Renal insufficiency (%) | 10 | 8 | 13 | 0.39 |
| LV end-diastolic diameter (mm) | 48 ± 7 | 48 ± 4 | 56 +10 | < 0.0001 |
| LV end-diastolic dimeter index (mm/m2) | 26 ± 4 | 27 ± 4 | 23 + 6 | < 0.0001 |
| Left ventricular end-systolic diameter (mm) | 31 ± 9 | 33 ± 9 | 41 + 13 | < 0.0001 |
| LV end-systolic dimeter index (mm/m2) | 16 ± 4 | 18 ± 4 | 41 + 13 | < 0.0001 |
| Ventricular septum (mm) | 14 ± 2 | 14 ± 3 | 14 + 3 | 0.2 |
| Posterior wall (mm) | 13 ± 2 | 13 ± 2 | 12 ± 2 | 0.13 |
| Relative wall thickness | 0.57 + 0.15 | 0.57 + 0.13 | 0.48 + 0.13 | 0.0006 |
| LV ejection fraction (%) | 62 ± 16 | 54 ± 17 | 45 ± 21 | < 0.0001 |
| Left atrial dimension (mm) | 41 ± 9 | 43 ± 8 | 48 ± 6 | < 0.0001 |
| Aortic valve area (cm2) | 0.72 + 0.16 | 0.68 + 0.16 | 0.70 + 0.20 | 0.18 |
| Aortic valve peak gradient (mmHg) | 73 ± 23 | 71 ± 26 | 67 +22 | 0.09 |
| Aortic valve mean gradient (mmHg) | 45 ± 15 | 43 ± 17 | 41 +15 | 0.08 |
| Aortic regurgitation grade | 0.65+0.83 | 1.16+0.91 | 1.00+1.00 | < 0.0001 |
| Mitral E/A velocity ratio | 1.00 + 0.53 | 1.09 + 0.64 | 1.60 + 0.67 | < 0.0001 |
| Mitral E wave deceleration time (ms) | 270 ± 105 | 278 ± 112 | 194 +89 | 0.0001 |
| Pulmonary artery systolic pressure (mmHg) | 40 ± 13 | 45 ± 20 | 53 +14 | < 0.0001 |
| Beta-blocker use (%) | 46 | 46 | 27 | 0.02 |
| ACEI or ARB use (%) | 25 | 33 | 36 | 0.12 |
| Digoxin use (%) | 35 | 32 | 38 | 0.47 |
| Statin use (%) | 31 | 21 | 35 | 0.09 |
| Coronary artery bypass grafting (%) | 38 | 49 | 47 | 0.12 |
| Mitral valve repair (%) | 3 | 2 | 20 | < 0.0001 |
| Mitral valve replacement (%) | 2 | 10 | 13 | 0.06 |
Table 2 Results of Cox regression analysis on the effect of mitral regurgitation on survival
| Variable | χ2 value | P value |
| LV end-diastolic dimension | 10.4 | < 0.01 |
| LV ejection fraction | 23.3 | < 0.0001 |
| Mitral regurgitation | 7.9 | < 0.01 |
- Citation: Pai RG, Varadarajan P. Importance of concomitant functional mitral regurgitation on survival in severe aortic stenosis patients undergoing aortic valve replacement. World J Cardiol 2023; 15(5): 253-261
- URL: https://www.wjgnet.com/1949-8462/full/v15/i5/253.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i5.253
